Jpmorgan Chase & CO Personalis, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Personalis, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 200 shares of PSNL stock, worth $1,044. This represents 0.0% of its overall portfolio holdings.

Number of Shares

200

Previous 200 -0.0%

Holding current value

$1,044

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$1.15 - $2.19 $788 - $1,502	-686 Reduced 77.43%	200 $0
Q4 2023 Dec 26, 2024	BUY	$0.93 - $2.35 $637 - $1,612	686 Added 343.0%	886 $1,000
Q4 2023 Feb 12, 2024	SELL	$0.93 - $2.35 $3.29 Million - $8.31 Million	-3,535,231 Reduced 99.97%	886 $1,000
Q3 2023 Nov 14, 2023	SELL	$1.19 - $2.36 $59,829 - $118,653	-50,277 Reduced 1.4%	3,536,117 $4.28 Million
Q2 2023 Aug 11, 2023	SELL	$1.8 - $3.19 $74,388 - $131,833	-41,327 Reduced 1.14%	3,586,394 $6.74 Million
Q1 2023 May 11, 2023	BUY	$2.01 - $4.17 $250,208 - $519,089	124,482 Added 3.55%	3,627,721 $10 Million
Q4 2022 Feb 13, 2023	SELL	$1.78 - $3.64 $480,883 - $983,378	-270,159 Reduced 7.16%	3,503,239 $6.94 Million
Q3 2022 Nov 14, 2022	SELL	$2.89 - $5.32 $249,545 - $459,371	-86,348 Reduced 2.24%	3,773,398 $11.2 Million
Q2 2022 Aug 11, 2022	SELL	$3.27 - $8.76 $1.28 Million - $3.42 Million	-390,459 Reduced 9.19%	3,859,746 $13.3 Million
Q1 2022 May 11, 2022	SELL	$7.56 - $14.3 $228,145 - $431,545	-30,178 Reduced 0.71%	4,250,205 $34.8 Million
Q4 2021 Feb 10, 2022	SELL	$12.24 - $21.25 $930,729 - $1.62 Million	-76,040 Reduced 1.75%	4,280,383 $61.1 Million
Q3 2021 Nov 12, 2021	BUY	$16.69 - $26.05 $72.7 Million - $113 Million	4,356,423 New	4,356,423 $83.8 Million

Others Institutions Holding PSNL

# of Institutions

Shares Held

30.3M

Call Options Held

27.5K

Put Options Held

85.4K

View Full List

About Personalis, Inc.

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $240M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

More about PSNL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Personalis, Inc. Transaction History